
Gregory S. Emch
Examiner (ID: 8394, Phone: (571)272-8149 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1678, 1699, 1649 |
| Total Applications | 893 |
| Issued Applications | 386 |
| Pending Applications | 80 |
| Abandoned Applications | 436 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16964220
[patent_doc_number] => 20210215719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => BLOOD BIOMARKER FOR DISCERNING BETA AMYLOID ACCUMULATION IN BRAIN
[patent_app_type] => utility
[patent_app_number] => 16/496547
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496547
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496547 | Blood biomarker for discerning beta amyloid accumulation in brain | Mar 21, 2018 | Issued |
Array
(
[id] => 15880437
[patent_doc_number] => 10646543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Methods and compositions for treating trinucleotide repeat disorders
[patent_app_type] => utility
[patent_app_number] => 15/916719
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 12
[patent_no_of_words] => 17704
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15916719
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/916719 | Methods and compositions for treating trinucleotide repeat disorders | Mar 8, 2018 | Issued |
Array
(
[id] => 15586481
[patent_doc_number] => 20200069775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => BRAIN OSTEOCALCIN RECEPTOR AND COGNITIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/486428
[patent_app_country] => US
[patent_app_date] => 2018-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486428
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486428 | BRAIN OSTEOCALCIN RECEPTOR AND COGNITIVE DISORDERS | Feb 14, 2018 | Abandoned |
Array
(
[id] => 16842887
[patent_doc_number] => 11014961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Self-labeling miniproteins and conjugates comprising them
[patent_app_type] => utility
[patent_app_number] => 16/480199
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 37
[patent_no_of_words] => 19457
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480199
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480199 | Self-labeling miniproteins and conjugates comprising them | Jan 24, 2018 | Issued |
Array
(
[id] => 13431041
[patent_doc_number] => 20180267063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => METHOD OF IDENTIFYING BIOMARKERS OF NEUROLOGICAL DISEASES AND DIAGNOSIS OF NEUROLOGICAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/880303
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15880303
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/880303 | METHOD OF IDENTIFYING BIOMARKERS OF NEUROLOGICAL DISEASES AND DIAGNOSIS OF NEUROLOGICAL DISEASES | Jan 24, 2018 | Abandoned |
Array
(
[id] => 18086602
[patent_doc_number] => 11536731
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Systems and methods for binding amyloid fibrils using fluorescent protein
[patent_app_type] => utility
[patent_app_number] => 16/480216
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2119
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480216
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480216 | Systems and methods for binding amyloid fibrils using fluorescent protein | Jan 22, 2018 | Issued |
Array
(
[id] => 13357385
[patent_doc_number] => 20180230232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => SINGLE DOMAIN ANTIBODIES CAPABLE OF MODULATING BACE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 15/872498
[patent_app_country] => US
[patent_app_date] => 2018-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15872498
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/872498 | Single domain antibodies capable of modulating BACE activity | Jan 15, 2018 | Issued |
Array
(
[id] => 15114565
[patent_doc_number] => 20190343915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => PEPTIDES FOR THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/477092
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16477092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/477092 | Laminin receptor peptides for therapy | Jan 11, 2018 | Issued |
Array
(
[id] => 12733093
[patent_doc_number] => 20180136198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => SYNAPTIC VESICLE CYCLING ASSAYS AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 15/868200
[patent_app_country] => US
[patent_app_date] => 2018-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15868200
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/868200 | SYNAPTIC VESICLE CYCLING ASSAYS AND SYSTEMS | Jan 10, 2018 | Abandoned |
Array
(
[id] => 13733195
[patent_doc_number] => 20180371065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => Human Anti-Alpha-Synuclein Antibodies
[patent_app_type] => utility
[patent_app_number] => 15/865378
[patent_app_country] => US
[patent_app_date] => 2018-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15865378
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/865378 | Human anti-alpha-synuclein antibodies | Jan 8, 2018 | Issued |
Array
(
[id] => 13325909
[patent_doc_number] => 20180214492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => Repair of Peripheral Nerve Injury
[patent_app_type] => utility
[patent_app_number] => 15/863278
[patent_app_country] => US
[patent_app_date] => 2018-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15863278
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/863278 | Repair of peripheral nerve injury | Jan 4, 2018 | Issued |
Array
(
[id] => 15751347
[patent_doc_number] => 10617756
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-14
[patent_title] => Drug regimen for treatment of cerebral ischemia
[patent_app_type] => utility
[patent_app_number] => 15/859075
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4784
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15859075
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/859075 | Drug regimen for treatment of cerebral ischemia | Dec 28, 2017 | Issued |
Array
(
[id] => 13342863
[patent_doc_number] => 20180222971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => COMPOUNDS AND METHODS FOR TREATING PAIN
[patent_app_type] => utility
[patent_app_number] => 15/849771
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15849771
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/849771 | Compounds and methods for treating pain | Dec 20, 2017 | Issued |
Array
(
[id] => 16398812
[patent_doc_number] => 20200339670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => NOVEL MEANS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/955815
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955815
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955815 | NOVEL MEANS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | Dec 19, 2017 | Abandoned |
Array
(
[id] => 14993777
[patent_doc_number] => 20190315846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Antibodies to Human Alpha-Synuclein
[patent_app_type] => utility
[patent_app_number] => 16/466713
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466713
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466713 | Antibodies to Human Alpha-Synuclein | Dec 6, 2017 | Abandoned |
Array
(
[id] => 14762101
[patent_doc_number] => 10392435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Method for decreasing depression-like behavior with connective tissue growth factor (CTGF) inhibitor
[patent_app_type] => utility
[patent_app_number] => 15/833273
[patent_app_country] => US
[patent_app_date] => 2017-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19834
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15833273
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/833273 | Method for decreasing depression-like behavior with connective tissue growth factor (CTGF) inhibitor | Dec 5, 2017 | Issued |
Array
(
[id] => 13829025
[patent_doc_number] => 20190017997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => USE OF PAK4 AND CRTC1 FOR TREATMENT OR DIAGNOSIS OF BRAIN DEGENERATIVE DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/824273
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15824273
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/824273 | USE OF PAK4 AND CRTC1 FOR TREATMENT OR DIAGNOSIS OF BRAIN DEGENERATIVE DISEASE | Nov 27, 2017 | Abandoned |
Array
(
[id] => 15119651
[patent_doc_number] => 20190346458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => GFAP ACCUMULATING IN STROKE
[patent_app_type] => utility
[patent_app_number] => 16/462520
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462520
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462520 | GFAP accumulating in stroke | Nov 19, 2017 | Issued |
Array
(
[id] => 15119651
[patent_doc_number] => 20190346458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => GFAP ACCUMULATING IN STROKE
[patent_app_type] => utility
[patent_app_number] => 16/462520
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462520
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462520 | GFAP accumulating in stroke | Nov 19, 2017 | Issued |
Array
(
[id] => 15119651
[patent_doc_number] => 20190346458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => GFAP ACCUMULATING IN STROKE
[patent_app_type] => utility
[patent_app_number] => 16/462520
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462520
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462520 | GFAP accumulating in stroke | Nov 19, 2017 | Issued |